Lilly (LLY) Inks Metabolic Disorders Therapy Development Deal Posted byZacks Equity Research December 13, 2021 Leave a comment on Lilly (LLY) Inks Metabolic Disorders Therapy Development Deal Lilly (LLY) inks a strategic collaboration with Regor Therapeutics to discover and develop novel therapies for metabolic disorders.